VIP Peptide: What It Is and Its U.S. Regulatory Status

What is VIP?

Vasoactive intestinal peptide (VIP) is a naturally occurring neuropeptide made of 28 amino acids. It was first isolated from the intestine in 1970, which is where its name comes from. It is now known to be made in many tissues, including the brain, gut, lungs and heart.

VIP belongs to the same peptide family as glucagon and secretin. It acts on receptors called VPAC1 and VPAC2.

A synthetic form of VIP, called aviptadil, has been studied in clinical trials, including trials in people with respiratory failure related to COVID-19. Aviptadil has not been approved by the FDA.

U.S. regulatory status

Current status: Not FDA-approved.

In practical terms, VIP has not gone through the FDA review that a drug must pass before it can be marketed for use in people. There is no FDA-approved product that contains it.

Why Peptide Labs does not sell VIP

Peptide Labs does not sell this compound. This page is general information, not medical advice. We do not supply VIP, and we do not point readers to anyone who does.

For personal medical questions, including questions about VIP, the right person to ask is a licensed healthcare provider.

Related reading

See the full list of compound profiles in the Peptide Guide.